Quote this publication Share Print

NOVOEIGHT

-
Opinions on drugs - Posted on Sep 10 2014

Reason for request

Inclusion

 -  


Clinical Benefit

Substantial

The actual benefit of NOVOEIGHT is substantial.


Clinical Added Value

no clinical added value

NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments.